339 related articles for article (PubMed ID: 11737656)
1. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis.
Choi J; Borrello MA; Smith E; Cutler CW; Sojar H; Zauderer M
Oral Microbiol Immunol; 2001 Dec; 16(6):338-44. PubMed ID: 11737656
[TBL] [Abstract][Full Text] [Related]
2. Polarization of Porphyromonas gingivalis-specific helper T-cell subsets by prior immunization with Fusobacterium nucleatum.
Choi JI; Borrello MA; Smith ES; Zauderer M
Oral Microbiol Immunol; 2000 Jun; 15(3):181-7. PubMed ID: 11154401
[TBL] [Abstract][Full Text] [Related]
3. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model.
Gemmell E; Bird PS; Ford PJ; Ashman RB; Gosling P; Hu Y; Seymour GJ
Oral Microbiol Immunol; 2004 Aug; 19(4):247-51. PubMed ID: 15209995
[TBL] [Abstract][Full Text] [Related]
5. Induction of systemic murine B-cell responses by Fusobacterium nucleatum and Porphyromonas gingivalis.
Nunes IP; Jonsson R; Jensen HB; Bakken V
Oral Microbiol Immunol; 1996 Jun; 11(3):142-9. PubMed ID: 8941767
[TBL] [Abstract][Full Text] [Related]
6. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
[TBL] [Abstract][Full Text] [Related]
7. Immunization to Porphyromonas gingivalis enhances the local pro-inflammatory response to subcutaneous bacterial challenge.
Houri-Haddad Y; Soskoine WA; Shapira L
J Clin Periodontol; 2001 May; 28(5):476-82. PubMed ID: 11350512
[TBL] [Abstract][Full Text] [Related]
8. Evidence for serum immunoglobulin G (IgG) antibody responses in Macaca fascicularis identified by monoclonal antibodies to human IgG subclasses.
Ebersole JL; Bauman GR; Cox O'Dell SE; Giardino A
Oral Microbiol Immunol; 1997 Aug; 12(4):193-203. PubMed ID: 9467387
[TBL] [Abstract][Full Text] [Related]
9. Cell envelope and cell wall immunization of Macaca fascicularis: effect on the progression of ligature-induced periodontitis.
Holt SC; Brunsvold M; Jones A; Wood R; Ebersole JL
Oral Microbiol Immunol; 1995 Dec; 10(6):321-33. PubMed ID: 8602339
[TBL] [Abstract][Full Text] [Related]
10. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.
Herminajeng E; Sosroseno W; Bird PS; Seymour GJ
J Periodontol; 2001 Nov; 72(11):1527-34. PubMed ID: 11759864
[TBL] [Abstract][Full Text] [Related]
11. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies to Porphyromonas gingivalis chaperone HtpG predict health in periodontitis susceptible patients.
Shelburne CE; Shelburne PS; Dhople VM; Sweier DG; Giannobile WV; Kinney JS; Coulter WA; Mullally BH; Lopatin DE
PLoS One; 2008 Apr; 3(4):e1984. PubMed ID: 18431474
[TBL] [Abstract][Full Text] [Related]
13. Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis.
Gemmell E; Winning TA; Carter CL; Ford PJ; Bird PS; Ashman RB; Grieco DA; Seymour GJ
Oral Microbiol Immunol; 2003 Dec; 18(6):364-70. PubMed ID: 14622342
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
Yang QB; Martin M; Michalek SM; Katz J
Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice.
Gemmell E; Sernia C; Grieco DA; Bird PS; Allen CJ; Seymour GJ
Oral Microbiol Immunol; 2001 Jun; 16(3):129-35. PubMed ID: 11358534
[TBL] [Abstract][Full Text] [Related]
16. Different responses in B cells induced by Porphyromonas gingivalis and Fusobacterium nucleatum.
Gemmell E; Seymour GJ
Arch Oral Biol; 1992; 37(7):565-73. PubMed ID: 1359860
[TBL] [Abstract][Full Text] [Related]
17. Participation of glutathione in the elimination of Porphyromonas gingivalis in vivo.
Kato C; Mikami M; Natsuno T
Oral Microbiol Immunol; 2008 Dec; 23(6):441-8. PubMed ID: 18954348
[TBL] [Abstract][Full Text] [Related]
18. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
19. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
Katz J; Black KP; Michalek SM
Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874
[TBL] [Abstract][Full Text] [Related]
20. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X; LaRosa KB; Kawai T; Taubman MA
Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
